In ALCL, pre-clinical models have shown a positive correlation between PD-L1 expression in the tumor cells and TAMs in ALK-positive ALCL and conversely, a negative correlation in ALK-negative ALCL [39,40]. This evidence concerns the gene ALK and neoplasm.